These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 22927137

  • 1. Repeated dosing of piperine induced gene expression of P-glycoprotein via stimulated pregnane-X-receptor activity and altered pharmacokinetics of diltiazem in rats.
    Qiang F, Kang KW, Han HK.
    Biopharm Drug Dispos; 2012 Nov; 33(8):446-54. PubMed ID: 22927137
    [Abstract] [Full Text] [Related]

  • 2. Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats.
    Choi JS, Han HK.
    Int J Pharm; 2005 Nov 23; 305(1-2):122-8. PubMed ID: 16226412
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of oral bioavailability and immune response of Ginsenoside Rh2 by co-administration with piperine.
    Jin ZH, Qiu W, Liu H, Jiang XH, Wang L.
    Chin J Nat Med; 2018 Feb 23; 16(2):143-149. PubMed ID: 29455730
    [Abstract] [Full Text] [Related]

  • 4. Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats.
    Hong SP, Choi DH, Choi JS.
    Cardiovasc Ther; 2008 Feb 23; 26(4):269-75. PubMed ID: 19035878
    [Abstract] [Full Text] [Related]

  • 5. Enhanced Oral Bioavailability of Domperidone with Piperine in Male Wistar Rats: Involvement of CYP3A1 and P-gp Inhibition.
    Athukuri BL, Neerati P.
    J Pharm Pharm Sci; 2017 Feb 23; 20():28-37. PubMed ID: 28459658
    [Abstract] [Full Text] [Related]

  • 6. Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Cho YA, Choi DH, Choi JS.
    J Pharm Pharmacol; 2009 Jun 23; 61(6):825-9. PubMed ID: 19505375
    [Abstract] [Full Text] [Related]

  • 7. Effects of morin pretreatment on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem in rats.
    Choi HJ, Choi JS.
    Arch Pharm Res; 2005 Aug 23; 28(8):970-6. PubMed ID: 16178425
    [Abstract] [Full Text] [Related]

  • 8. Enhanced oral bioavailability of piperine by self-emulsifying drug delivery systems: in vitro, in vivo and in situ intestinal permeability studies.
    Shao B, Cui C, Ji H, Tang J, Wang Z, Liu H, Qin M, Li X, Wu L.
    Drug Deliv; 2015 Aug 23; 22(6):740-7. PubMed ID: 24670090
    [Abstract] [Full Text] [Related]

  • 9. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction.
    Jin MJ, Han HK.
    J Food Sci; 2010 Apr 23; 75(3):H93-6. PubMed ID: 20492299
    [Abstract] [Full Text] [Related]

  • 10. Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Hong SP, Chang KS, Choi DH, Choi JS.
    Arch Pharm Res; 2007 Jan 23; 30(1):90-5. PubMed ID: 17328247
    [Abstract] [Full Text] [Related]

  • 11. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
    Li C, Choi JS.
    Pharmazie; 2008 Nov 23; 63(11):815-8. PubMed ID: 19069242
    [Abstract] [Full Text] [Related]

  • 12. Effect of piperine on the bioavailability and pharmacokinetics of emodin in rats.
    Di X, Wang X, Di X, Liu Y.
    J Pharm Biomed Anal; 2015 Nov 10; 115():144-9. PubMed ID: 26201645
    [Abstract] [Full Text] [Related]

  • 13. Effects of piperine on the intestinal permeability and pharmacokinetics of linarin in rats.
    Feng X, Liu Y, Wang X, Di X.
    Molecules; 2014 Apr 30; 19(5):5624-33. PubMed ID: 24786847
    [Abstract] [Full Text] [Related]

  • 14. The protective effect of piperine on dextran sulfate sodium induced inflammatory bowel disease and its relation with pregnane X receptor activation.
    Hu D, Wang Y, Chen Z, Ma Z, You Q, Zhang X, Liang Q, Tan H, Xiao C, Tang X, Gao Y.
    J Ethnopharmacol; 2015 Jul 01; 169():109-23. PubMed ID: 25907981
    [Abstract] [Full Text] [Related]

  • 15. Effects of lovastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats: possible role of cytochrome P450 3A4 and P-glycoprotein inhibition by lovastatin.
    Hong SP, Yang JS, Han JY, Ha SI, Chung JW, Koh YY, Chang KS, Choi DH.
    J Pharm Pharmacol; 2011 Jan 01; 63(1):129-35. PubMed ID: 21189658
    [Abstract] [Full Text] [Related]

  • 16. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
    Cherniakov I, Izgelov D, Domb AJ, Hoffman A.
    Eur J Pharm Sci; 2017 Nov 15; 109():21-30. PubMed ID: 28736128
    [Abstract] [Full Text] [Related]

  • 17. Reduced Systemic and Brain Exposure with Inhibited Liver Metabolism of Carbamazepine After Its Long-Term Combination Treatment with Piperine for Epilepsy Control in Rats.
    Ren T, Xiao M, Yang M, Zhao J, Zhang Y, Hu M, Cheng Y, Xu H, Zhang C, Yan X, Zuo Z.
    AAPS J; 2019 Jul 18; 21(5):90. PubMed ID: 31321577
    [Abstract] [Full Text] [Related]

  • 18. Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment.
    Katiyar SS, Muntimadugu E, Rafeeqi TA, Domb AJ, Khan W.
    Drug Deliv; 2016 Sep 18; 23(7):2608-2616. PubMed ID: 26036652
    [Abstract] [Full Text] [Related]

  • 19. Improved effectiveness of biochanin A as a P-gp inhibitor in solid dispersion.
    Han HK, Lee HK.
    Pharmazie; 2011 Sep 18; 66(9):710-5. PubMed ID: 22026129
    [Abstract] [Full Text] [Related]

  • 20. Piperine-loaded nanoparticles with enhanced dissolution and oral bioavailability for epilepsy control.
    Ren T, Hu M, Cheng Y, Shek TL, Xiao M, Ho NJ, Zhang C, Leung SSY, Zuo Z.
    Eur J Pharm Sci; 2019 Sep 01; 137():104988. PubMed ID: 31291598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.